Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Can moderate alcohol use still cause nutrient deficiencies
Traditional formulations often suffer from issues like: Poor encapsulation of sensitive or water-repelling (hydrophobic) actives Inconsistent particle size, leading to unpredictable bioavailability and targeting Rapid degradation or leakage, resulting in short shelf life Difficulties maintaining performance when scaling from lab to production Liposome encapsulation solves these problems by: Maximizes absorption, especially for oral and topical delivery Extends circulation time for longer therapeutic effect Minimizes toxicity through targeted or controlled release Shields fragile actives such as mRNA, enzymes, and probiotics from degradation At BOC Sciences, we address these obstacles head-on through advanced liposome encapsulation technology
Pharmacol, Biochem Behav 89:56371
Gastroenterology 160 , 287301.e20 (2021)
Synuclein in Parkinsons disease
Retatrutide is a triple GLP-1, GIP, and glucagon receptor agonist under clinical investigation for obesity, but it is not licensed by the MHRA or EMA in the UK
US$ 21.83
US$ 28.03
US$ 29.08
US$ 28.79
